Other reports however suggest that anti‐CSF1R inhibitor appeared to re‐educate macrophages rather than decreasing their numbers in mouse glioma, correlating with tumor size reduction (Pyonteck et al, 2013). The gene discussed is CSF1R; the disease is neoplasm.